NICOLE SANDERS: Open Payments
NPI 1386154722 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 51 payments from 17 companies in 2025. Trend: 2023 $394 · 2024 $694 · 2025 $1,525
Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $348 |
| Abbott Laboratories | 4 | $328 |
| Novo Nordisk Inc | 3 | $181 |
| Novartis Pharmaceuticals Corporation | 11 | $173 |
| Amgen Inc. | 5 | $100 |
| CVRx, Inc. | 3 | $72 |
| Merck Sharp & Dohme LLC | 4 | $63 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
| Stryker Corporation | 1 | $36 |
Products named: Kerendia, CARDIOMEMS, LEQVIO, Ozempic, AMPLATZER AMULET, REPATHA, Barostim Neo System, ELIQUIS.
Industry payments across TX — which companies pay providers there.
